System for intravenous delivery of a beneficial agent

Claim 2

An intravenous delivery system for administering a drug formulation to a patient, comprising in combination: (a) a reservoir of a pharmaceutically acceptable intravenously administrable fluid; (b) a formulation chamber comprising: (1) a wall surrounding a lumen; (2) an inlet in the wall that communicates with the reservoir to permit fluid to flow from the reservoir into the formulation chamber; (3) a beneficial intravenously administrable drug in the formulation chamber, said drug present in an amount for performing a beneficial program, and which drug forms a drug formulation with the intravenously administrable fluid that enters the chamber; (4) a drug release rate membrane in the formulation chamber formed of a material that releases drug formulation from the chamber concomitantly with the passage of intravenously administrable fluid that flows through the chamber; and, (5) an outlet in the wall that permits drug formulation and the intravenously administrable fluid to leave the formulation chamber.

Claim 3

The intravenous delivery system for administering the drug formulation according to claim 1, wherein the drug release rate membrane in the formulation chamber is adjacent to the outlet of the formulation chamber.

Claim 4

The intravenous delivery system for administering the drug formulation according to claim 1, wherein the formulation chamber additionally contains a filter for removing unwanted particulate matter from the intravenously administrable fluid that passes through the formulation chamber.

Claim 5

The intravenous delivery system for administering the drug formulation according to claim 1, wherein the formulation chamber contains a filter for removing unwanted bacteria thereby aiding in maintaining a sterile solution, which filter is adjacent to the release rate membrane.

Claim 6

The intravenous delivery system for administering the formulation according to claim 1 wherein a tubing extends from the outlet of the formulation chamber and is connected to a skin piercing means for administering the formulation to the patient.

Claim 7

A drug formulation chamber sized and adapted for use with an intravenous delivery system, the formulation chamber comprising: (a) a wall that surrounds an internal lumen; (b) an inlet in the wall adapted for placing the formulation chamber into an intravenous delivery system, which inlet communicates with the lumen and lets an intravenously administrable fluid enter the formulation chamber; (c) a beneficial, intravenously acceptable drug present in a therapeutically effective amount for producing a beneficial effect in the lumen, which drug forms an intravenously administrable drug formulation in situ with fluid that enters the chamber for intravenously administering it to a recipient; (d) a drug release rate film in the internal lumen that release the beneficial drug formulation from the chamber simultaneously with intravenously administrable fluid that flows through the chamber; and, (e) an outlet in the wall adapted for placing the formulation chamber into an intravenously delivery system, which outlet communicates with the lumen and lets drug formulation and fluid leave the formulation chamber.

Claim 8

A drug formulation chamber sized and adapted for use with an intravenous delivery system, the formulation chamber comprising: (a) a wall that surrounds an internal lumen; (b) an inlet in the wall adapted for placing the formulation chamber into an intravenous delivery system, which inlet communicates with the lumen and lets an intravenously administrable fluid enter the formulation chamber; (c) a beneficial, intravenously acceptable drug present in a therapeutically effective amount for producing a beneficial effect in the lumen, which drug forms an intravenously administrable drug formulation in situ with fluid that enters the chamber for intravenously administering it to a recipient; (d) a drug release rate film in the internal lumen that release the beneficial drug formulation from the chamber simultaneously with intravenously administrable fluid that flows through the chamber; and, (e) an outlet in the wall adapted for placing the formulation chamber into an intravenously delivery system, which outlet communicates with the lumen and lets drug formulation and fluid leave the formulation chamber.

Claim 9

The formulation chamber for use with the intravenous delivery system according to claim 6, wherein the formulation chamber comprises an additional film adjacent to the inlet in the wall for controlling the flow of fluid into the chamber.

Claim 10

The formulation chamber for use with the intravenous delivery system according to claim 6, wherein the drug releasing film is adjacent to the outlet.

Claim 11

The formulation chamber for use in an intravenous delivery system according to claim 6, wherein the chamber additionally contains a filter.

Claim 12

A formulation chamber for use with an intravenous delivery system, the formulation chamber comprising: (a) a wall that surrounds an internal lumen; (b) an inlet in the wall that communicates with the lumen and lets an intravenously administrable fluid enter the formulation chamber; (c) a beneficial intravenously administrable drug presented in a therapeutically effective amount for producing a beneficial effect in tablet form that undergoes dissolution over time in the lumen, which drug forms an intravenously administrable drug formulation with fluid that enters the chamber for intravenously administering it to a recipient; (d) a drug release rate film in the internal lumen that releases the beneficial drug formulation from the chamber simultaneously with intravenously administrable fluid that flows through the chamber; and, (e) an outlet in the wall that communicates with the lumen and lets drug formulation and fluid leave the formulation chamber.

Claim 13

A formulation chamber for use with an intravenous delivery system, the formulation chamber comprising: (a) a wall that surrounds an internal lumen; (b) an inlet in the wall that communicates with the lumen and lets an intravenously administrable fluid enter the formulation chamber; (c) a beneficial intravenously administrable drug presented in a therapeutically effective amount for producing a beneficial effect in tablet form that undergoes dissolution over time in the lumen, which drug forms an intravenously administrable drug formulation with fluid that enters the chamber for intravenously administering it to a recipient; (d) a drug release rate film in the internal lumen that releases the beneficial drug formulation from the chamber simultaneously with intravenously administrable fluid that flows through the chamber; and, (e) an outlet in the wall that communicates with the lumen and lets drug formulation and fluid leave the formulation chamber.

Claim 14

A formulation chamber for use with an intravenous delivery system, the formulation chamber comprising: (a) a wall that surrounds an internal lumen; (b) an inlet in the wall that communicates with the lumen and lets an intravenously administrable fluid enter the formulation chamber; (c) a beneficial intravenously administrable drug present in a therapeutically effective amount for producing a beneficial effect in a lyophilized form in the lumen, which drug forms an intravenously administrable drug formulation with fluid that enters the chamber for intravenously administering it to a recipient; (d) a drug release rate film in the internal lumen that releases the beneficial drug formulation from the chamber simultaneously with intravenously administrable fluid that flows through the chamber; and, (e) an outlet in the wall that communicates with the lumen and lets drug formulation and fluid leave the formulation chamber.

Claim 15

A formulation chamber for use with an intravenous delivery system, the formulation chamber comprising: (a) a wall that surrounds an internal lumen; (b) an inlet in the wall that communicates with the lumen and lets an intravenously administrable fluid enter the formulation chamber; (c) a beneficial intravenously administrable drug present in a therapeutically effective amount for producing a beneficial effect in a lyophilized form in the lumen, which drug forms an intravenously administrable drug formulation with fluid that enters the chamber for intravenously administering it to a recipient; (d) a drug release rate film in the internal lumen that releases the beneficial drug formulation from the chamber simultaneously with intravenously administrable fluid that flows through the chamber; and, (e) an outlet in the wall that communicates with the lumen and lets drug formulation and fluid leave the formulation chamber.

Claim 16

The formulation chamber for use with the intravenous delivery system according to claim 6, wherein the drug releasing film is formed of a microporous drug releasing material and the beneficial drug is dry for mixing with the intravenously administrable fluid that enters the formulation chamber and forms a drug formulation that is released by the film from the formulation chamber.

Claim 17

The formulation chamber for use with the intravenous delivery system according to claim 6, wherein the drug releasing film is formed of a semipermeable material.

Claim 18

The formulation chamber for use with the intravenous delivery system according to claim 6, wherein the drug releasing film is formed of a diffusional material.

Claim 19

The formulation chamber for use with the intravenous delivery system according to claim 6, wherein the film forms an area containing the drug.

Claim 20

The formulation chamber for use in an intravenous delivery system according to claim 6, wherein the formulation chamber is in fluid communication with a drip chamber.

Claim 21

The formulation chamber for use in an intravenous delivery system according to claim 6, wherein formulation chamber is additionally a drip chamber.

Claim 22

The drug formulation chamber for use with the intravenous delivery system according to claim 6, wherein the beneficial intravenously administrable drug in the lumen is a solid in an effective amount for executing a beneficial program.

Claim 23

A drug formulation chamber sized and adapted for use with an intravenous delivery system, the formulation chamber comprising: (a) a wall that surrounds an internal lumen; (b) an inlet in the wall adapted for placing the formulation chamber into an intravenous delivery system, which inlet communicates with the lumen and lets an intravenously administrable fluid enter the formulation chamber; (c) a beneficial intravenously administrable dry drug in a therapeutically effective amount for producing a beneficial effect when administered to a recipient in the lumen; (d) a film in the internal lumen that defines an area containing the drug, which drug forms an intravenously administrable drug formulation in situ with an intravenously administrable fluid that enters the chamber for intravenously administering to a recipient and, (e) an outlet in the wall adapted for placing the formulation chamber into an intravenous delivery system, which outlet communicates with the lumen and lets drug formulation and fluid leave the formulation chamber.

Claim 24

A drug formulation chamber sized and adapted for use with an intravenous delivery system, the formulation chamber comprising: (a) a wall that surrounds an internal lumen; (b) an inlet in the wall adapted for placing the formulation chamber into an intravenous delivery system, which inlet communicates with the lumen and lets an intravenously administrable fluid enter the formulation chamber; (c) a beneficial intravenously administrable dry drug in a therapeutically effective amount for producing a beneficial effect when administered to a recipient in the lumen; (d) a film in the internal lumen that defines an area containing the drug, which drug forms an intravenously administrable drug formulation in situ with an intravenously administrable fluid that enters the chamber for intravenously administering to a recipient and, (e) an outlet in the wall adapted for placing the formulation chamber into an intravenous delivery system, which outlet communicates with the lumen and lets drug formulation and fluid leave the formulation chamber.